Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.


SecurityHGT / Hugoton Royalty Trust (444717102)
IndustryOil Royalty Traders
Institutional Owners42
Institutional Shares5,228,675
Institutional Value$ 4,702,000 USD

Institutional Stock Ownership and Shareholders()

HGT / Hugoton Royalty Trust Institutional Ownership

Hugoton Royalty Trust (NYSE:HGT) has 42 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5,228,675 shares. Largest shareholders include Wells Fargo & Company/mn, Steel Partners Holdings L.p., Royce & Associates LLC, Greenwich Investment Management, Inc., Price Michael F, California Public Employees Retirement System, Susquehanna International Group, Llp, Bank Of America Corp /de/, Royal Bank Of Canada, and FMR LLC / Fidelity.
Hugoton Royalty Trust (NYSE:HGT) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/hgt"><img src="https://images.fintel.io/us-hgt-so.png" alt="HGT / Hugoton Royalty Trust Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 11,221 11,221 0.00 16 8 -50.00
2018-04-23 13F-HR Diligent Investors, LLC 17,808 16,908 -5.05 25 12 -52.00
2018-05-17 13F-HR Atlantic Trust Group, LLC 11 11 0.00 0 0
2018-07-11 13F-HR Gierl Augustine Investment Management Inc 107 107 0.00 0 0
2018-05-15 13F-HR TWO SIGMA SECURITIES, LLC 52,539 20,236 -61.48 74 14 -81.08
2018-04-20 13F-HR Seacrest Wealth Management, Llc 1,500 1,500 0.00 2 1 -50.00
2018-04-24 13F-HR Rehmann Capital Advisory Group 24 0
2018-07-09 13F-HR Capital Investment Advisors, LLC 12,946 12,486 -3.55 9 8 -11.11
2018-05-14 13F-HR MORGAN STANLEY 58,262 37,467 -35.69 82 25 -69.51
2018-02-16 13F-HR/A Commonwealth Equity Services, Inc 10,550 10,562 0.11 19 20 5.26
2018-05-14 13F-HR IHT Wealth Management, LLC 690 0 -100.00 1 0 -100.00
2018-05-15 13F-HR PANAGORA ASSET MANAGEMENT INC 37,231 26
2018-05-10 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 1 1 0.00 0 0
2018-05-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 3,628 3,630 0.06 5 2 -60.00
2017-02-08 13F-HR Geduld E E 25,000 54
2018-05-10 13F-HR JP Morgan Chase & Co 546 546 0.00 1 0 -100.00
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 25,079 21,679 -13.56 35 15 -57.14
2018-05-11 13F-HR CITIGROUP INC 2,120 2,120 0.00 3 1 -66.67
2018-04-10 13F-HR Atlanta Capital Group 14,600 0 -100.00 20 0 -100.00
2018-05-07 13F-HR Greenwich Investment Management, Inc. 155,901 234,804 50.61 218 164 -24.77
2018-05-15 13F-HR DEUTSCHE BANK AG\ 155,011 0 -100.00 217 0 -100.00
2018-05-14 13F-HR Virtu Financial LLC 40,485 0 -100.00 57 0 -100.00
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 186,000 186,000 0.00 260 130 -50.00
2017-08-18 13F-HR WFG Advisors, LP 300 0 -100.00 1 0 -100.00
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 52,505 52,505 0.00 74 37 -50.00
2018-04-17 13F-HR INGALLS & SNYDER LLC 90,721 0 -100.00 127 0 -100.00
2018-05-14 13F-HR PRICE MICHAEL F 190,440 190,440 0.00 267 133 -50.19
2018-05-11 13F-HR SEI INVESTMENTS CO 5 3 -40.00 0 0
2018-07-20 13F-HR Cornerstone Wealth Management, LLC 659 1,000
2018-07-03 13F-HR NEVILLE RODIE & SHAW INC 17,500 17,500 0.00 12 11 -8.33
2018-05-09 13F-HR IFP Advisors, Inc 1,689 1,689 0.00 2 1 -50.00
2018-05-15 13F-HR UBS Group AG 18,601 12,001 -35.48 26 8 -69.23
2018-05-14 13F-HR STEEL PARTNERS HOLDINGS L.P. 1,000,000 1,000,000 0.00 1,400 700 -50.00
2018-05-14 13F-HR FMR LLC / Fidelity 50,000 50,000 0.00 70 35 -50.00
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 34,027 118,360 247.84 48 83 72.92
2018-05-14 13F-HR Royce & Associates LLC 287,574 287,574 0.00 403 201 -50.12
2018-04-20 13F-HR Cable Hill Partners, LLC 4 5 25.00 0 0
2018-05-14 13F-HR Commonwealth Equity Services, Llc. 10,601 0 -100.00 15 0 -100.00
2018-07-20 13F-HR Creative Planning 10,932 0 -100.00 8 0 -100.00
2018-05-15 13F-HR GUGGENHEIM CAPITAL LLC 0 10,255 0 7
2018-02-09 13F-HR Hawkins Capital L.P. 99,610 0 -100.00 184 0 -100.00
2018-07-20 13F-HR GOODWIN DANIEL L 11,010 11,010 0.00 8 7 -12.50
2018-05-09 13F-HR Cetera Advisor Networks LLC 11,100 0 -100.00 16 0 -100.00
2018-04-09 13F-HR Merriman Wealth Management, LLC 15,000 11
2018-05-14 13F-HR Sanctuary Wealth Advisors, LLC 16,833 9,838 -41.56 236 7 -97.03
2018-05-14 13F-HR Renaissance Technologies LLC 154,911 0 -100.00 217 0 -100.00
2018-07-19 13F-HR HUNTINGTON NATIONAL BANK 2,500 2,500 0.00 2 2 0.00
2018-05-14 13F-HR/A CITADEL ADVISORS LLC 44,420 0 -100.00 62 0 -100.00
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 2,237,374 2,713,727 21.29 3,132 1,899 -39.37
2018-05-11 13F-HR GSA CAPITAL PARTNERS LLP 10,751 10,751 0.00 15 8 -46.67
2017-10-26 13F-HR Acrospire Investment Management LLC 10,665 0 -100.00 19 0 -100.00
2018-05-15 13F-HR LPL Financial LLC 0 12,013 0 8
2018-05-14 13F-HR Capital Analysts, Inc. 5,434 0 -100.00 1,242 0 -100.00
2018-04-18 13F-HR REGIONS FINANCIAL CORP 274 274 0.00 0 0
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 119,744 90,835 -24.14 168 64 -61.90
2018-05-14 13F-HR Heritage Trust Co 203 203 0.00 0 0

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 444717102